Comprehensive Financial Consultants Institutional Inc. Purchases Shares of 3,260 Synopsys, Inc. $SNPS

Key Points

• Comprehensive Financial Consultants Institutional Inc. acquired 3,260 shares of Synopsys, Inc., valued at approximately $1,671,000, during the second quarter.
• Recent insider trading activities include CFO Shelagh Glaser selling 3,655 shares at $609.77 and Director Robert G. Painter purchasing 350 shares at $425.44.
• Synopsys stock is currently down 0.4% with a market cap of $87.15 billion and a consensus rating of "Hold" from analysts.

Comprehensive Financial Consultants Institutional Inc. purchased a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 3,260 shares of the semiconductor company's stock, valued at approximately $1,671,000.

A number of other institutional investors have also bought and sold shares of the company. MCF Advisors LLC boosted its position in Synopsys by 16.2% during the second quarter. MCF Advisors LLC now owns 136 shares of the semiconductor company's stock valued at $70,000 after acquiring an additional 19 shares during the last quarter. Trust Point Inc. raised its holdings in shares of Synopsys by 4.4% during the second quarter. Trust Point Inc. now owns 494 shares of the semiconductor company's stock valued at $253,000 after purchasing an additional 21 shares during the period. Whelan Financial raised its holdings in shares of Synopsys by 4.1% during the second quarter. Whelan Financial now owns 534 shares of the semiconductor company's stock valued at $274,000 after purchasing an additional 21 shares during the period. Quent Capital LLC raised its holdings in shares of Synopsys by 1.8% during the second quarter. Quent Capital LLC now owns 1,204 shares of the semiconductor company's stock valued at $617,000 after purchasing an additional 21 shares during the period. Finally, Hardy Reed LLC raised its holdings in shares of Synopsys by 0.7% during the first quarter. Hardy Reed LLC now owns 3,290 shares of the semiconductor company's stock valued at $1,411,000 after purchasing an additional 22 shares during the period. Institutional investors own 85.47% of the company's stock.

Insider Buying and Selling at Synopsys

In other Synopsys news, CFO Shelagh Glaser sold 3,655 shares of the stock in a transaction that occurred on Friday, September 5th. The shares were sold at an average price of $609.77, for a total value of $2,228,709.35. Following the sale, the chief financial officer directly owned 15,317 shares in the company, valued at $9,339,847.09. This represents a 19.27% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Robert G. Painter bought 350 shares of the stock in a transaction on Thursday, September 11th. The stock was purchased at an average price of $425.44 per share, for a total transaction of $148,904.00. Following the completion of the purchase, the director directly owned 2,291 shares in the company, valued at approximately $974,683.04. This represents a 18.03% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders sold a total of 30,894 shares of company stock valued at $16,760,783 in the last quarter. Corporate insiders own 0.62% of the company's stock.

Synopsys Stock Down 0.4%

SNPS opened at $469.17 on Monday. The company has a 50 day moving average of $559.15 and a 200 day moving average of $510.22. The company has a market cap of $87.15 billion, a PE ratio of 36.83, a price-to-earnings-growth ratio of 5.17 and a beta of 1.10. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $651.73. The company has a current ratio of 1.62, a quick ratio of 1.51 and a debt-to-equity ratio of 0.52.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the stock. Wall Street Zen lowered shares of Synopsys from a "hold" rating to a "sell" rating in a report on Saturday, September 13th. Stifel Nicolaus dropped their price objective on shares of Synopsys from $650.00 to $550.00 and set a "buy" rating on the stock in a report on Wednesday, September 10th. Baird R W lowered shares of Synopsys from a "strong-buy" rating to a "hold" rating in a report on Wednesday, September 10th. Rosenblatt Securities reiterated a "neutral" rating and set a $605.00 price objective (down previously from $650.00) on shares of Synopsys in a report on Wednesday, September 10th. Finally, Robert W. Baird reiterated a "neutral" rating and set a $535.00 price objective (down previously from $670.00) on shares of Synopsys in a report on Wednesday, September 10th. Eleven investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $575.31.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.